Lakefront Biotherapeutics American Depositary Shares

LKFT XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.8B

Short interest (Jul 15)

3.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

1.91%

↑ 16.0%

Available Shares

↑ 37.8%

Price Chart

Company Overview

Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.

Company Info

Exchange: NASDAQ

CIK: 0001421876

Asset Type: ADRC

Market Data

Market Cap: $1,823,093,212

Employees: 452

Status: Active

Short Interest

Current Borrow Fee 1.91%

Range: 1.46% - 1.91%

Available Shares 2M

Range: 650K - 1.9M

Recent Changes

Fee Change: ↑ 3.4%

Available Change: ↑ 2.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime